Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1994-09-06
1995-12-26
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424469, 424470, 424474, 424480, 424484, 424488, 424494, 514252, 514256, 514963, 514964, 514965, A61K 31505, A61K 952, A61K 926
Patent
active
054785723
ABSTRACT:
Gepirone compositions having extended release properties contain a gepirone salt, a cellulosic polymer matrix and suitable quantities of pharmaceutical excipients. Dosage forms based thereon require 18 to 24 hours for release of 90 to 95% of gepirone.
REFERENCES:
patent: 3870790 (1975-03-01), Lowey et al.
patent: 3965256 (1976-06-01), Leslie
patent: 4226849 (1980-10-01), Schor
patent: 4235870 (1980-11-01), Leslie
patent: 4248856 (1981-02-01), Guley et al.
patent: 4248858 (1981-02-01), Guley et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4357469 (1982-11-01), Schor
patent: 4369172 (1983-01-01), Schor et al.
patent: 4389393 (1983-06-01), Schor et al.
patent: 4415547 (1983-11-01), Yu et al.
patent: 4423049 (1983-12-01), Temple
patent: 4547358 (1985-10-01), David et al.
patent: 4610870 (1986-09-01), Jain et al.
patent: 4690824 (1987-09-01), Powell et al.
patent: 4695591 (1987-09-01), Hanna et al.
patent: 4704284 (1987-11-01), Beatty et al.
patent: 4771053 (1988-09-01), Cott et al.
patent: 4782060 (1988-11-01), Kurtz et al.
patent: 4942040 (1990-07-01), Ragnarsson et al.
patent: 4981695 (1991-01-01), Appelgren et al.
patent: 5096908 (1992-03-01), Gidda et al.
patent: 5106849 (1992-04-01), Abou-Gharbia et al.
patent: 5124346 (1992-06-01), Seymour
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5292766 (1994-03-01), Clemens
patent: 5378846 (1995-01-01), Seredenin et al.
patent: 5387604 (1995-02-01), McDonald et al.
Ford et al., "Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets", International Journal of Pharmaceuticals, 40 pp. 223-224 (1987).
Chou Joseph C. H.
David Stephen T.
Gallian Claude E.
Bristol-Myers Squibb Co.
Griffin Ronald W.
Nolan Sandra M.
LandOfFree
Gepirone dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gepirone dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gepirone dosage form will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1367389